middle.news
How Will Zelira’s US$33M Raise Propel HOPE 1 Autism Drug Trials?
9:34am on Thursday 29th of January, 2026 AEDT
•
Biotechnology
Read Story
How Will Zelira’s US$33M Raise Propel HOPE 1 Autism Drug Trials?
9:34am on Thursday 29th of January, 2026 AEDT
Key Points
US$32.98 million raised for HOPE 1 SPV, valuing it at US$66 million post-money
Zelira retains 39.7% equity in HOPE 1 SPV after fundraising
FDA 505(b)(2) regulatory pathway targeted for accelerated approval
Received $1.07 million Australian R&D tax incentive refund
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ZELIRA THERAPEUTICS (ASX:ZLD)
OPEN ARTICLE